GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » EPS (Diluted)

ClouDr Group (HKSE:09955) EPS (Diluted) : HK$-0.66 (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group EPS (Diluted)?

ClouDr Group's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$-0.34. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.66.

ClouDr Group's EPS (Basic) for the six months ended in Dec. 2023 was HK$-0.34. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.66.

ClouDr Group's EPS without NRI for the six months ended in Dec. 2023 was HK$-0.34. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.66.

During the past 3 years, the average EPS without NRIGrowth Rate was 52.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, ClouDr Group's highest 3-Year average EPS without NRI Growth Rate was 52.10% per year. The lowest was -78.00% per year. And the median was -12.95% per year.


ClouDr Group EPS (Diluted) Historical Data

The historical data trend for ClouDr Group's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group EPS (Diluted) Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
-1.09 -5.98 -8.92 -6.28 -0.66

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial -3.48 -2.46 -0.87 -0.32 -0.34

Competitive Comparison of ClouDr Group's EPS (Diluted)

For the Medical Distribution subindustry, ClouDr Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClouDr Group's PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where ClouDr Group's PE Ratio falls into.



ClouDr Group EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

ClouDr Group's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-353.362-0)/540.820
=-0.65

ClouDr Group's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-182.73-0)/549.417
=-0.33

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ClouDr Group  (HKSE:09955) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


ClouDr Group EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of ClouDr Group's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


ClouDr Group (HKSE:09955) Business Description

Traded in Other Exchanges
Address
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

ClouDr Group (HKSE:09955) Headlines

No Headlines